XTLB – X.T.L. Biopharmaceuticals Ltd. ADR
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
0.69
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
1.41
Target Price
6
Analyst Recom
1
Performance Q
-19.43
Relative Volume
1.04
Beta
1.07
Ticker: XTLB
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | XTLB | 1.88 | N/A | N/A | 0 |
| 2025-01-24 | XTLB | 1.8484 | N/A | N/A | 0 |
| 2025-01-27 | XTLB | 1.7 | N/A | N/A | 0 |
| 2025-01-28 | XTLB | 1.61 | N/A | N/A | 0 |
| 2025-01-29 | XTLB | 1.62 | N/A | N/A | 0 |
| 2025-01-30 | XTLB | 1.58 | N/A | N/A | 0 |
| 2025-01-31 | XTLB | 1.5899 | N/A | N/A | 0 |
| 2025-02-03 | XTLB | 1.6238 | N/A | N/A | 0 |
| 2025-02-04 | XTLB | 1.7 | N/A | N/A | 0 |
| 2025-02-05 | XTLB | 1.67 | N/A | N/A | 0 |
| 2025-02-06 | XTLB | 1.61 | N/A | N/A | 0 |
| 2025-02-07 | XTLB | 1.66 | N/A | N/A | 0 |
| 2025-02-10 | XTLB | 1.67 | N/A | N/A | 0 |
| 2025-02-11 | XTLB | 1.61 | N/A | N/A | 0 |
| 2025-02-12 | XTLB | 1.72 | N/A | N/A | 0 |
| 2025-02-13 | XTLB | 1.66 | N/A | N/A | 0 |
| 2025-02-14 | XTLB | 1.74 | N/A | N/A | 0 |
| 2025-02-18 | XTLB | 1.55 | N/A | N/A | 0 |
| 2025-02-19 | XTLB | 1.5 | N/A | N/A | 0 |
| 2025-02-20 | XTLB | 1.51 | N/A | N/A | 0 |
| 2025-02-21 | XTLB | 1.43 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | XTLB | 1.88 | - | - | - |
| 2025-01-24 | XTLB | 1.88 | - | - | - |
| 2025-01-27 | XTLB | 1.70 | - | - | - |
| 2025-01-28 | XTLB | 1.54 | - | - | - |
| 2025-01-29 | XTLB | 1.61 | - | - | - |
| 2025-01-30 | XTLB | 1.57 | - | - | - |
| 2025-01-31 | XTLB | 1.57 | - | - | - |
| 2025-02-03 | XTLB | 1.70 | - | - | - |
| 2025-02-04 | XTLB | 1.67 | - | - | - |
| 2025-02-05 | XTLB | 1.67 | - | - | - |
| 2025-02-06 | XTLB | 1.67 | - | - | - |
| 2025-02-07 | XTLB | 1.61 | - | - | - |
| 2025-02-10 | XTLB | 1.63 | - | - | - |
| 2025-02-11 | XTLB | 1.63 | - | - | - |
| 2025-02-12 | XTLB | 1.67 | - | - | - |
| 2025-02-13 | XTLB | 1.66 | - | - | - |
| 2025-02-14 | XTLB | 1.74 | - | - | - |
| 2025-02-18 | XTLB | 1.55 | - | - | - |
| 2025-02-19 | XTLB | 1.52 | - | - | - |
| 2025-02-20 | XTLB | 1.52 | - | - | - |
| 2025-02-21 | XTLB | 1.41 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | XTLB | 0.00 | -87.16 | 0.75 |
| 2025-01-24 | XTLB | 0.00 | -87.16 | 0.75 |
| 2025-01-27 | XTLB | 0.00 | -87.51 | 0.75 |
| 2025-01-28 | XTLB | 0.00 | -87.51 | 0.75 |
| 2025-01-29 | XTLB | 0.00 | -87.51 | 0.75 |
| 2025-01-30 | XTLB | 0.00 | -87.51 | 0.75 |
| 2025-01-31 | XTLB | 0.00 | -87.51 | 0.75 |
| 2025-02-03 | XTLB | 0.00 | -86.95 | 0.75 |
| 2025-02-04 | XTLB | 0.00 | -86.95 | 0.75 |
| 2025-02-05 | XTLB | 0.00 | -86.95 | 0.75 |
| 2025-02-06 | XTLB | 0.00 | -86.95 | 0.75 |
| 2025-02-07 | XTLB | 0.00 | -86.95 | 0.75 |
| 2025-02-10 | XTLB | 0.00 | -83.18 | 0.75 |
| 2025-02-11 | XTLB | 0.00 | -83.18 | 0.75 |
| 2025-02-12 | XTLB | 0.00 | -83.18 | 0.69 |
| 2025-02-13 | XTLB | 0.00 | -83.18 | 0.69 |
| 2025-02-14 | XTLB | 0.00 | -83.18 | 0.69 |
| 2025-02-18 | XTLB | 0.00 | -84.70 | 0.69 |
| 2025-02-19 | XTLB | 0.00 | -84.70 | 0.69 |
| 2025-02-20 | XTLB | 0.00 | -84.70 | 0.69 |
| 2025-02-21 | XTLB | 0.00 | -84.70 | 0.69 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-84.7
Beta
1.07
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
24
Growth Score
Sentiment Score
7
Actual DrawDown %
78.9
Max Drawdown 5-Year %
-85.4
Target Price
6
P/E
Forward P/E
PEG
P/S
110.51
P/B
3.09
P/Free Cash Flow
EPS
-0.14
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-651.85
Relative Volume
1.04
Return on Equity vs Sector %
-37.7
Return on Equity vs Industry %
-22.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
stock quote shares XTLB – X.T.L. Biopharmaceuticals Ltd. ADR Stock Price stock today
news today XTLB – X.T.L. Biopharmaceuticals Ltd. ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch XTLB – X.T.L. Biopharmaceuticals Ltd. ADR yahoo finance google finance
stock history XTLB – X.T.L. Biopharmaceuticals Ltd. ADR invest stock market
stock prices XTLB premarket after hours
ticker XTLB fair value insiders trading